Animal Antibiotics and Antimicrobials Market: By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins and Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection and Others) By Animal Type (Food-Producing Animals, Companion Animals), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Animal Antibiotics and Antimicrobials Market size was valued at USD 4,561.3 million in 2022. It is expected to reach a value of USD 6,083.6 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The global market provides a detailed overview of the animal antibiotics and antimicrobials market, which can be segmented by product type, mode of delivery, and animal type. By product type, the animal antibiotics and antimicrobials market has been segmented into tetracyclines, penicillin, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. The penicillins segment is likely to be the largest and fastest-growing segment in terms of product type. Based on the mode of delivery, the animal antibiotics and antimicrobials market is segmented into premixes, oral powder, oral solution, injection, and others. Among these, the premixes segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on animal type, the market is segregated into food-producing animals and companion animals. The food-producing animal segment held a considerable market share during the forecast period.  

Animal Antibiotics and Antimicrobials Market Key Developments:

In Jul 2020, Zoetis collaborated with Trianni, Inc to build transgenic monoclonal antibody platforms to develop novel veterinary therapeutics. 

Animal Antibiotics And Antimicrobials Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Animal Antibiotics and Antimicrobials Market Dynamics

Pet insurance increases primarily due to the increased cost of veterinarian services and treatments, increased demand for cattle-related items, and growth due to increased public awareness of various animal diseases are some key factors fostering the market growth.

Animal Antibiotics And Antimicrobials Market Segmentation

By Product Type
  • Tetracyclines,
  • Penicillins,
  • Sulfonamides,
  • Macrolides,
  • Aminoglycosides,
  • Lincosamides,
  • Fluoroquinolones,
  • Cephalosporins and Other Antimicrobials and
  • Antibiotics
By Mode of Delivery
  • Premixes,
  • Oral Powder,
  • Oral Solution,
  • Injection and
  • Others
By Animal Type
  • Food-Producing Animals,
  • Companion Animals

Frequently Asked Questions

The animal antibiotics and antimicrobials market size was valued at USD 4,561.3 million in 2022

The major players in the global animal antibiotics and antimicrobials market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK) and Kyoritsu Seiyaku (Japan).

North America is the fastest-growing region for animal antibiotics and antimicrobials market

Key Features of the Reports

  • The animal antibiotics and antimicrobials market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Animal Antibiotics and Antimicrobials Market Introduction
2.1. Global Animal Antibiotics and Antimicrobials Market Taxonomy
2.2. Global Animal Antibiotics and Antimicrobials Market Definitions
2.2.1. By Product Type
2.2.2. By Mode of Delivery
2.2.3. By Animal Type
2.2.4. By Region
3. Global Animal Antibiotics and Antimicrobials Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Animal Antibiotics and Antimicrobials Market Dynamic Factors - Impact Analysis
3.6. Global Animal Antibiotics and Antimicrobials Market Competition Landscape
4. Global Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Animal Antibiotics and Antimicrobials Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Tetracyclines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Penicillins
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Sulfonamides
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Macrolides
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5.  Aminoglycosides
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6.  Lincosamides
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Fluoroquinolones
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8.  Cephalosporins
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Other Antimicrobials and Antibiotics
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Animal Antibiotics and Antimicrobials Market, By Mode of Delivery, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Premixes
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Oral Powder
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Oral Solution
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Injection
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Animal Antibiotics and Antimicrobials Market, By Animal Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Food Processing Animals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Companion Animals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Animal Antibiotics and Antimicrobials Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Region, 2024 - 2030
9. North America Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tetracyclines
9.1.2. Penicillins
9.1.3. Sulfonamides
9.1.4. Macrolides
9.1.5. Aminoglycosides
9.1.6. Lincosamides
9.1.7. Fluoroquinolones
9.1.8. Cephalosporins
9.1.9.  Other Antimicrobials and Antibiotics
9.2. Mode of Delivery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Premixes
9.2.2. Oral Powder
9.2.3. Oral Solution
9.2.4. Injection
9.2.5. Others
9.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Food-Producing Animals
9.3.2. Companion Animals
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2024 - 2030
9.6. North America Animal Antibiotics and Antimicrobials Market Dynamics Trends
10. Europe Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tetracyclines
10.1.2. Penicillins
10.1.3. Sulfonamides
10.1.4. Macrolides
10.1.5. Aminoglycosides
10.1.6. Lincosamides
10.1.7. Fluoroquinolones
10.1.8. Cephalosporins
10.1.9.  Other Antimicrobials and Antibiotics
10.2. Mode of Delivery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Premixes
10.2.2. Oral Powder
10.2.3. Oral Solution
10.2.4. Injection
10.2.5. Others
10.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Food-Producing Animals
10.3.2. Companion Animals
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Rest of Europe
10.5. Europe Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2024 - 2030
10.6. Europe Animal Antibiotics and Antimicrobials Market Dynamics Trends
11. Asia-Pacific Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tetracyclines
11.1.2. Penicillins
11.1.3. Sulfonamides
11.1.4. Macrolides
11.1.5. Aminoglycosides
11.1.6. Lincosamides
11.1.7. Fluoroquinolones
11.1.8. Cephalosporins
11.1.9.  Other Antimicrobials and Antibiotics
11.2. Mode of Delivery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Premixes
11.2.2. Oral Powder
11.2.3. Oral Solution
11.2.4. Injection
11.2.5. Others
11.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Food-Producing Animals
11.3.2. Companion Animals
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2024 - 2030
11.6. Asia-Pacific Animal Antibiotics and Antimicrobials Market Dynamics Trends
12. Latin America Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Tetracyclines
12.1.2. Penicillins
12.1.3. Sulfonamides
12.1.4. Macrolides
12.1.5. Aminoglycosides
12.1.6. Lincosamides
12.1.7. Fluoroquinolones
12.1.8. Cephalosporins
12.1.9.  Other Antimicrobials and Antibiotics
12.2. Mode of Delivery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Premixes
12.2.2. Oral Powder
12.2.3. Oral Solution
12.2.4. Injection
12.2.5. Others
12.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Food-Producing Animals
12.3.2. Companion Animals
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2024 - 2030
12.6. Latin America Animal Antibiotics and Antimicrobials Market Dynamics Trends
13. Middle East and Africa Animal Antibiotics and Antimicrobials Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Tetracyclines
13.1.2. Penicillins
13.1.3. Sulfonamides
13.1.4. Macrolides
13.1.5. Aminoglycosides
13.1.6. Lincosamides
13.1.7. Fluoroquinolones
13.1.8. Cephalosporins
13.1.9.  Other Antimicrobials and Antibiotics
13.2. Mode of Delivery Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Premixes
13.2.2. Oral Powder
13.2.3. Oral Solution
13.2.4. Injection
13.2.5. Others
13.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Food-Producing Animals
13.3.2. Companion Animals
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. MEA Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2024 - 2030
13.6. MEA Animal Antibiotics and Antimicrobials Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Boehringer Ingelheim (Germany)
14.2.2.  Zoetis Inc. (US)
14.2.3.  Elanco Animal Health (US)
14.2.4.  Merck & Co. Inc (US)
14.2.5.  Phibro Animal Health (US)
14.2.6.  Virbac (France)
14.2.7.  Vetoquinol S.A. (France)
14.2.8.  Ceva Santé Animale (France)
14.2.9.  Dechra Pharmaceuticals Plc (UK)
14.2.10.  Kyoritsu Seiyaku (Japan)
15. Research Methodology
16. Key Assumptions and Acronyms
  • Boehringer Ingelheim (Germany)
  • Zoetis Inc. (US)
  • Elanco Animal Health (US)
  • Merck & Co. Inc (US)
  • Phibro Animal Health (US)
  • Virbac (France)
  • Vetoquinol S.A. (France)
  • Ceva Santé Animale (France)
  • Dechra Pharmaceuticals Plc (UK)
  • Kyoritsu Seiyaku (Japan)

Adjacent Markets